Assignee
METABOGEN AB
SE·4 granted patents·3 pending applications·2 citations·filing 2013–2022
Top patents by PatentIndex Score
7 records- 0167US12318412B2Faecalibacterium prausnitzii and Desulfovibrio piger for use in the treatment or prevention of diabetes and bowel diseasesMETABOGEN AB·Filed 2022·Granted Jun 3, 2025·0 cites·18 claims
- 0262US9881135B2Identification of a person having risk for developing type 2 diabetesMETABOGEN AB·Filed 2013·Granted Jan 30, 2018·2 cites·20 claims
- 0356US2015299776A1Identification of a Person having Risk for Atherosclerosis and Associated Disease by the Person's Gut Microbiome and the Prevention of such DiseasesMETABOGEN AB·Filed 2013·Application pending·0 cites
- 0451US10876092B2Method for adaptationMETABOGEN AB·Filed 2016·Granted Dec 29, 2020·0 cites·11 claims
- 0549US2018179584A1Identification of a Person having Risk for Atherosclerosis and Associated Disease by the Person's Gut Microbiome and the Prevention of such DiseasesMETABOGEN AB·Filed 2018·Application pending·0 cites
- 0643US11260082B2Faecalibacterium prausnitzii and Desulfovibrio piger for use in the treatment or prevention of diabetes and bowel diseasesMETABOGEN AB·Filed 2016·Granted Mar 1, 2022·0 cites·11 claims
- 0742US2018369297A1Treatment of intrahepatic cholestasis and related liver diseasesMETABOGEN AB·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when METABOGEN AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →